Insider trading

Period: 120 months Stock: EW + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

612 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

612 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

612 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

612 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
612 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
612 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

612 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
11 Mar 2024
Lemercier Jean-Luc M CVP, EMEACLA and JAPAC
Sold on a plan
$1.32M 14,400 at 91.68
7.7%
Planned (10b5-1)
7 Mar 2024
Lippis Daniel J. CVP, JAPAC
Sold on a plan
$156.03K 1,715 at 90.98
9.1%
Planned (10b5-1)
4 Mar 2024
Sold on a plan 2×
$2.54M 29,350 at 86.67
86.7%
Sold half or more
29 Feb 2024
Ullem Scott B. CVP, Chief Financial Officer
Sold on a plan
$620.92K 7,255 at 85.59
27.6%
Planned (10b5-1)
23 Feb 2024
GALLAHUE KIERAN Director · indirect
Sold at will
$267.91K 3,058 at 87.61
4.4%
Not planned
21 Feb 2024
Chopra Daveen CVP, TMTT
Sold at will 2×
$711.27K 8,200 at 86.74
26.5%
Not planned
15 Feb 2024
Szyman Catherine M. CVP, Critical Care
Sold at will
$2.31M 27,000 at 85.62
43.7%
Not planned
13 Feb 2024
Szyman Catherine M. CVP, Critical Care
Sold at will
$1.73M 20,000 at 86.46
36.5%
Not planned
13 Feb 2024
BOBO DONALD E JR CVP,Strategy/Corp Development
Sold on a plan 2×
$944.16K 11,000 at 85.83
21.8%
Planned (10b5-1)
12 Feb 2024
SELLERS ROBERT W.A. SVP, Corporate Controller
Sold at will
$1.06M 12,210 at 87.00
48.3%
Not planned
8 Feb 2024
Sold at will
$609.99K 7,056 at 86.45
20.7%
Not planned
5 Feb 2024
Sold on a plan 4×
$2.57M 29,350 at 87.49
86.7%
Sold half or more
1 Feb 2024
Ullem Scott B. CVP, Chief Financial Officer
Sold on a plan
$567.99K 7,255 at 78.29
27.4%
Planned (10b5-1)
12 Jan 2024
BOBO DONALD E JR CVP,Strategy/Corp Development
Sold on a plan
$756.70K 10,000 at 75.67
20.2%
Planned (10b5-1)
5 Jan 2024
Sold on a plan 2×
$2.14M 29,350 at 72.98
86.7%
Sold half or more
29 Dec 2023
Ullem Scott B. CVP, Chief Financial Officer
Sold on a plan
$1.11M 14,510 at 76.55
43.0%
Planned (10b5-1)
15 Dec 2023
Chopra Daveen CVP, TMTT
Sold at will
$547.72K 7,000 at 78.25
22.6%
Not planned
13 Dec 2023
Sold on a plan 4×
$2.19M 29,350 at 74.62
86.7%
Sold half or more
13 Dec 2023
Wood Larry L Global President TAVR & Surg
Sold on a plan
$622.16K 8,658 at 71.86
3.9%
Planned (10b5-1)
13 Dec 2023
BOBO DONALD E JR CVP,Strategy/Corp Development
Sold on a plan
$574.88K 8,000 at 71.86
16.8%
Planned (10b5-1)
6 Dec 2023
Chopra Daveen CVP, TMTT
Sold on a plan
$245.01K 3,500 at 70.00
12.8%
Planned (10b5-1)
13 Nov 2023
Wood Larry L Global President TAVR & Surg
Sold on a plan 3×
$565.46K 8,660 at 65.30
3.9%
Planned (10b5-1)
13 Nov 2023
BOBO DONALD E JR CVP,Strategy/Corp Development
Sold on a plan 2×
$391.78K 6,000 at 65.30
13.2%
Planned (10b5-1)
3 Nov 2023
Sold on a plan
$1.97M 29,350 at 67.18
86.7%
Sold half or more
31 Oct 2023
Ullem Scott B. CVP, Chief Financial Officer
Sold on a plan
$454.57K 7,255 at 62.66
27.4%
Planned (10b5-1)
13 Oct 2023
Wood Larry L Global President TAVR & Surg
Sold on a plan 2×
$606.20K 8,660 at 70.00
3.9%
Planned (10b5-1)
13 Oct 2023
BOBO DONALD E JR CVP,Strategy/Corp Development
Sold on a plan 2×
$349.91K 5,000 at 69.98
11.2%
Planned (10b5-1)
10 Oct 2023
Szyman Catherine M. CVP, Critical Care
Sold on a plan
$363.40K 5,000 at 72.68
12.6%
Planned (10b5-1)
3 Oct 2023
Chopra Daveen CVP, TMTT
Sold on a plan
$595.00K 8,500 at 70.00
26.2%
Planned (10b5-1)
2 Oct 2023
Sold on a plan
$2.02M 29,350 at 68.84
86.7%
Sold half or more
29 Sep 2023
Ullem Scott B. CVP, Chief Financial Officer
Sold on a plan
$504.53K 7,255 at 69.54
27.4%
Planned (10b5-1)
14 Sep 2023
Wood Larry L Global President TAVR & Surg
Sold on a plan
$637.62K 8,660 at 73.63
3.9%
Planned (10b5-1)
14 Sep 2023
BOBO DONALD E JR CVP,Strategy/Corp Development
Sold on a plan
$331.70K 4,500 at 73.71
10.2%
Planned (10b5-1)
8 Sep 2023
Szyman Catherine M. CVP, Critical Care
Sold on a plan
$380.00K 5,000 at 76.00
12.6%
Planned (10b5-1)
6 Sep 2023
Chopra Daveen CVP, TMTT
Sold on a plan
$646.61K 8,500 at 76.07
26.2%
Planned (10b5-1)
5 Sep 2023
Sold on a plan
$2.23M 29,350 at 75.86
86.7%
Sold half or more
31 Aug 2023
Ullem Scott B. CVP, Chief Financial Officer
Sold on a plan
$564.37K 7,255 at 77.79
27.4%
Planned (10b5-1)
29 Aug 2023
Chopra Daveen CVP, TMTT
Sold at will
$115.04K 1,500 at 76.69
5.9%
Not planned
14 Aug 2023
Wood Larry L Global President TAVR & Surg
Sold on a plan
$509.19K 6,421 at 79.30
2.9%
Planned (10b5-1)
14 Aug 2023
BOBO DONALD E JR CVP,Strategy/Corp Development
Sold on a plan
$356.85K 4,500 at 79.30
10.2%
Planned (10b5-1)
10 Aug 2023
Sold at will
$260.51K 3,303 at 78.87
10.9%
Not planned
9 Aug 2023
Szyman Catherine M. CVP, Critical Care
Sold on a plan
$393.19K 5,000 at 78.64
12.6%
Planned (10b5-1)
7 Aug 2023
Sold on a plan 2×
$2.34M 29,350 at 79.87
35.1%
Planned (10b5-1)
31 Jul 2023
Ullem Scott B. CVP, Chief Financial Officer
Sold on a plan
$611.96K 7,255 at 84.35
27.4%
Planned (10b5-1)
14 Jul 2023
Wood Larry L Global President TAVR & Surg
Sold on a plan
$804.84K 8,660 at 92.94
3.9%
Planned (10b5-1)
14 Jul 2023
BOBO DONALD E JR CVP,Strategy/Corp Development
Sold on a plan
$325.28K 3,500 at 92.94
8.1%
Planned (10b5-1)
10 Jul 2023
Szyman Catherine M. CVP, Critical Care
Sold on a plan
$452.60K 5,000 at 90.52
12.6%
Planned (10b5-1)
5 Jul 2023
Sold on a plan 2×
$2.66M 29,350 at 90.78
35.1%
Planned (10b5-1)
30 Jun 2023
Ullem Scott B. CVP, Chief Financial Officer
Sold on a plan
$676.67K 7,255 at 93.27
27.4%
Planned (10b5-1)
14 Jun 2023
Wood Larry L Global President TAVR & Surg
Sold on a plan 2×
$780.68K 8,660 at 90.15
3.9%
Planned (10b5-1)
Showing 101–150 of 612. ← Newer Page 3 of 13 Older →